Sabine Semrau

Dr. Sabine Semrau

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2024 in Strahlentherapie und Onkologie
Verified
Journal Article
Open access
PDF file
Florian PutzFlorian Putz
Florian Putz
SBSogand Beirami
Sogand Beirami
MSManuel Schmidt
Manuel Schmidt
Matthias MayMatthias May
Matthias May
JGJohanna Grigo
Johanna Grigo
YHYixing Huang
Yixing Huang
Background: Promptable foundation auto-segmentation models like Segment Anything (SA, Meta AI, New York, USA) represent a novel class of universal deep learning auto-segmentation models that could be employed for interactive tumor auto-contouring in RT treatment planning. Methods: Segment Anything was evaluated in an interactive point-to-mask auto-segmentation task for glioma brain tumor auto-contouring in 16,744 transverse slices from 369 MRI datasets (BraTS 2020 dataset). Up to nine interactive point prompts were automatically placed per slice. Tumor boundaries were auto-segmented on contrast-enhanced T1w sequences. Out of the three auto-contours predicted by SA, accuracy was evaluated for the contour with the highest calculated IoU (Intersection over Union, “oracle mask,” simulating interactive model use with selection of the best tumor contour) and for the tumor contour with the highest model confidence (“suggested mask”). Results: Mean best IoU (mbIoU) using the best predicted tumor contour (oracle mask) in full MRI slices was 0.762 (IQR 0.713–0.917). The best 2D mask was achieved after a mean of 6.6 interactive point prompts (IQR 5–9). Segmentation accuracy was significantly better for high- compared to low-grade glioma cases (mbIoU 0.789 vs. 0.668). Accuracy was worse using the suggested mask (0.572). Stacking best tumor segmentations from transverse MRI slices, mean 3D Dice score for tumor auto-contouring was 0.872, which was improved to 0.919 by combining axial, sagittal, and coronal contours. Conclusion: The Segment Anything foundation segmentation model can achieve high accuracy for glioma brain tumor segmentation in MRI datasets. The results suggest that foundation segmentation models could facilitate RT treatment planning when properly integrated in a clinical application.

19 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SSSabine Semrau
Sabine Semrau
AGAntoniu Gostian
Antoniu Gostian
MTMaximilian Traxdorf
Maximilian Traxdorf
Markus EcksteinMarkus Eckstein
Markus Eckstein
RFRainer Fietkau
Rainer Fietkau
Markus HechtMarkus Hecht
Markus Hecht
To determine whether a single dose of double immune checkpoint blockade (induction chemoimmunotherapy (ICIT)) adds benefit to induction single-cycle platinum doublet (induction chemotherapy (IC)) in locally advanced head and neck squamous cell carcinoma (HNSCC), patients treated with cisplatin 30 mg/m2 d1-3 and docetaxel 75 mg/m2 d1 combined with durvalumab 1500 mg fixed dose d5 and tremelimumab 75 mg fixed dose d5 (ICIT) within the CheckRad-CD8 trial were compared with a retrospective cohort receiving the same chemotherapy (IC) without immunotherapy. The endpoint of this analysis was the complete response rate (CR). A total of 53 patients were treated with ICIT and 104 patients with IC only. CR rates were 60.3% for ICIT and 40.3% for IC (p = 0.018). In the total population (n = 157), the most important predictor to achieve a CR was treatment type (OR: 2.21 for ICIT vs. IC; p = 0.038, multivariate analysis). The most diverse effects in CR rates between ICIT and IC were observed in younger (age ≤ 60) patients with HPV-positive OPSCCs (82% vs. 33%, p = 0.176), while there was no difference in older patients without HPV-positive OPSCCs (53% vs. 48%). The analysis provides initial evidence that ICIT could result in higher CR rates than IC. Young patients with HPV-positive OPSCCs may have the greatest benefit from additional immune checkpoint inhibitors.

22 December 2010 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
SSSabine Semrau
Sabine Semrau
FWFrank Waldfahrer
Frank Waldfahrer
MLMichael Lell
Michael Lell
RLRainer Linke
Rainer Linke
GKGunther Klautke
Gunther Klautke
RFRainer Fietkau
Rainer Fietkau

23 December 2014 in Cancer
Verified
Journal Article
Open access
PDF file
SSSabine Semrau
Sabine Semrau
MHMarlen Haderlein
Marlen Haderlein
DSDaniela Schmidt
Daniela Schmidt
MLMichael Lell
Michael Lell
WWWalburga Wolf
Walburga Wolf
RFRainer Fietkau
Rainer Fietkau
BACKGROUND: There is controversy over the concept of function and organ preservation by chemotherapy/chemoradiation instead of surgery in locally advanced cancer of the larynx or pharynx. Tumor response to induction chemotherapy (ICT) can help in choosing between conservative and surgical treatment. This study compared 3 methods of assessing response to ICT: endoscopy, computed tomography, and 18F‐FDG‐PET/CT.METHODS: Primary response to 1 cycle of ICT with docetaxel plus platinum was assessed by the aforementioned methods in 62 laryngopharyngeal cancer patients. Endoscopic response was the deciding factor for selecting further treatment: surgery for endoscopic nonresponders (<30% tumor response) versus chemoradiotherapy for endoscopic responders.RESULTS: ICT achieved endoscopic response in 48 of 62 patients (77%). Individual relative residual tumor activity of standardized uptake value (resSUVmax) in 18F‐FDG‐PET/CT was a median 0.38 of baseline (0.09‐1.71), whereas residual tumor extent in CT (resCT) was 0.75 of baseline (0.32‐1.20). Endoscopic responders and nonresponders differed significantly in SUVmax after ICT (postSUVmax, 6.0 vs 14.5; P < .001), resSUVmax (0.34 vs 0.81, P < .001), and resCT (0.71 vs 0.87, P = .004), but not in maximum tumor diameter after ICT (14 vs 20 mm, P = .11). resSUVmax <0.8 and absolute postSUVmax <10 provided the best discriminatory power for long‐term success criteria (tumor‐free survival, overall survival).CONCLUSIONS: Metabolic tumor response showed very good correlation with clinical tumor response to ICT. The value of metabolic response detected by 18F‐FDG‐PET/CT should be explored in a prospective clinical trial. Cancer 2015;121:1214–1222. © 2014 American Cancer Society.

31 May 2013 in Oral Oncology
Verified
Journal Article
Closed access
SSSabine Semrau
Sabine Semrau
DSDaniela Schmidt
Daniela Schmidt
MLMichael Lell
Michael Lell
FWFrank Waldfahrer
Frank Waldfahrer
SLSebstian Lettmaier
Sebstian Lettmaier
RFRainer Fietkau
Rainer Fietkau

26 November 2020 in Cancers
Verified
Journal Article
Open access
PDF file
RGRebekka Götzl
Rebekka Götzl
SSSebastian Sterzinger
Sebastian Sterzinger
Andreas ArkudasAndreas Arkudas
Andreas Arkudas
Anja Miriam BoosAnja Miriam Boos
Anja Miriam Boos
SSSabine Semrau
Sabine Semrau
Justus BeierJustus Beier
Justus Beier
Background: Soft tissue sarcoma (STS) treatment is an interdisciplinary challenge. Along with radio(chemo)therapy, surgery plays the central role in STS treatment. Little is known about the impact of reconstructive surgery on STS, particularly whether reconstructive surgery enhances STS resection success with the usage of flaps. Here, we analyzed the 10-year experience at a university hospital’s Comprehensive Cancer Center, focusing on the role of reconstructive surgery. Methods: We performed a retrospective analysis of STS-patients over 10 years. We investigated patient demographics, diagnosis, surgical management, tissue/function reconstruction, complication rates, resection status, local recurrence and survival. Results: Analysis of 290 patients showed an association between clear surgical margin (R0) resections and higher-grade sarcoma in patients with free flaps. Major complications were lower with primary wound closure than with flaps. Comparison of reconstruction techniques showed no significant differences in complication rates. Wound healing was impaired in STS recurrence. The local recurrence risk was over two times higher with primary wound closure than with flaps. Conclusion: Defect reconstructions in STS are reliable and safe. Plastic surgeons should have a permanent place in interdisciplinary surgical STS treatment, with the full armamentarium of reconstruction methods.